SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043323
Filing Date
2024-05-15
Accepted
2024-05-15 11:56:01
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205748-10q_60degrees.htm   iXBRL 10-Q 808384
2 CERTIFICATION ea020574801ex31-1_60degrees.htm EX-31.1 11785
3 CERTIFICATION ea020574801ex31-2_60degrees.htm EX-31.2 11626
4 CERTIFICATION ea020574801ex32-1_60degrees.htm EX-32.1 4643
5 CERTIFICATION ea020574801ex32-2_60degrees.htm EX-32.2 4642
  Complete submission text file 0001213900-24-043323.txt   5967852

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sxtp-20240331.xsd EX-101.SCH 63633
7 XBRL CALCULATION FILE sxtp-20240331_cal.xml EX-101.CAL 52109
8 XBRL DEFINITION FILE sxtp-20240331_def.xml EX-101.DEF 320156
9 XBRL LABEL FILE sxtp-20240331_lab.xml EX-101.LAB 582571
10 XBRL PRESENTATION FILE sxtp-20240331_pre.xml EX-101.PRE 318154
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0205748-10q_60degrees_htm.xml XML 547905
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 24948502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)